Evaluating treatment protocols to prevent antibiotic resistance

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 22, 1997, Pages 12106-12111

  Bonhoeffer, Sebastian ^a,b   Lipsitch, Marc ^b   Levin, Bruce R ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE TRANSMISSION; HEALTH CARE POLICY; HUMAN; INFECTION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLINICAL PROTOCOLS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY; DRUG THERAPY, COMBINATION; EVALUATION STUDIES; HEALTH POLICY; HUMANS; MODELS, THEORETICAL; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS);

EID: 0030711752     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.22.12106     Document Type: Article

References (26)

1. Doern, G. V., Brueggemann, A., H. P. Holley, J. & Rauch, A. M. (1996) Antimicrob. Agents Chemother. 40, 1208-1213.
2. Cohen, M. L. (1994) Trends Microbiol. 2, 422-425.
3. Bloom, B. R. & Murray, C. J. L. (1992) Science 257, 1055-1064.
4. Swartz, M. N. (1994) Proc. Natl. Acad. Sci. (USA) 91, 2420-2427.
5. Arthur, M. & Courvalin, P. (1993) Antimicrob. Agents Chemother. 37, 1563-1571.
6. Jacoby, G. A. (1996) Ann. Rev. Med. 47, 169-179.
7. Murray, B. E. (1994) N. Engl. J. Med. 330, 1229-1230.
8. Jernigan, D. B., Cetron, M. S. & Breiman, R. F. (1996) J. Am. Med. Assoc. 275, 206-209.
9. Anonymous (1995) Am. J. Inf. Contr. 23, 87-94.
10. J. E. McGowan, J. (1986) Infect. Control 7, 573-576.
11. Massad, E., Lundberg, S. & Yang, H. M. (1993) Int. J. Bio-Med. Comput. 33, 65-81.
12. Blower, S. M., Small, P. M. & Hopewell, P. C. (1996) Science 273, 497-500.
13. May, R. M. & Dobson, A. P. (1986) Pesticide Resistance: Strategies and Tactics for Management (Natl. Acad. Sci., Washington, DC), pp. 170-193.
14. Lipsitch, M. & Levin, B. R. (1997) Antimicrob. Agents Chemother. 41, 363-373.
15. Bonhoeffer, S. & Nowak, M. A. (1997) Proc. R. Soc. London B 264, 631-637.
16. Bonhoeffer, S., May, R. M., Shaw, G. M. & Nowak, M. A. (1997) Proc. Natl. Acad. Sci. USA 94, 6971-6976.
17. Falkow, S. (1975) Infectious Multiple Drug Resistance (Pion, London).
18. Centers for Disease Control (1989) Morbid. Mortal. Wkly. Rep. 38, (Suppl. 3), 38.
19. Kam, K. M., Luey, K. Y., Fung, S. M., Yiu, P. P., Harden, T. J. & Cheung, M. M. (1995) Antimicrob. Agents Chemother. 39, 2667-2670.
20. Moran, J. S. & Levine, W. C. (1995) Clin. Infect. Dis. 20 (Suppl. 1), S47-S65.
21. Anderson, R. M. & May, R. M. (1991) Infectious Diseases of Humans (Oxford Univ. Press, Oxford).
22. Bouma, J. E. & Lenski, R. E. (1988) Nature (London) 335, 351-352.
23. Schrag, S. J. & Perrot, V. (1996) Nature (London) 381, 120-121.
24. Fekety, J. (1964) Medicine 45, 593-613.
25. Levin, B. R., Lipsitch, M., Perrot, V., Schrag, S., Antia, R., Simonsen, L., Moore, N. & Stewart, F. M. (1997) Clin. Infect. Dis. 24, Suppl. 1, S9-S16.
26. Haldane, J. (1957) J. Genet. 55, 511-524.